Patents by Inventor Chanda Macias

Chanda Macias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Menthol-derivative compounds and use thereof as oral and systemic active agents
    Patent number: 10426752
    Abstract: The present invention discloses novel uses of specific menthol-derivative compounds of Formula 1, and compositions thereof, for methods of providing oral and systemic health care benefits, and methods of up-regulating or down-regulating periodontal disease metabolites: Formula 1 wherein, X is an oxygen atom or an NH radical; and R is an unsubstituted or substituted aryl or aliphatic radical. In some embodiments, the oral and systemic health care benefits include biofilm anti-attachment, anti-inflammation, anti-oxidant, anti-bone loss, and anti-microbial benefits. In some embodiments, the periodontal disease metabolites correspond to healthy and/or diseased oral status and allow differential diagnosis of oral health.
    Type: Grant
    Filed: April 1, 2009
    Date of Patent: October 1, 2019
    Assignee: Colgate-Palmolive Company
    Inventors: Harsh M. Trivedi, Tao Xu, Davide Miksa, Cortney Worrell, Chanda Macias, Ying Yang, Yanan Hu
  • MENTHOL-DERIVATIVE COMPOUNDS AND USE THEREOF AS ORAL AND SYSTEMIC ACTIVE AGENTS
    Publication number: 20120014884
    Abstract: The present invention discloses novel uses of specific menthol-derivative compounds of Formula 1, and compositions thereof, for methods of providing oral and systemic health care benefits, and methods of up-regulating or down-regulating periodontal disease metabolites: Formula 1 wherein, X is an oxygen atom or an NH radical; and R is an unsubstituted or substituted aryl or aliphatic radical. In some embodiments, the oral and systemic health care benefits include biofilm anti-attachment, anti-inflammation, anti-oxidant, anti-bone loss, and anti-microbial benefits. In some embodiments, the periodontal disease metabolites correspond to healthy and/or diseased oral status and allow differential diagnosis of oral health.
    Type: Application
    Filed: April 1, 2009
    Publication date: January 19, 2012
    Applicant: Colgate-Palmolive Company
    Inventors: Harsh M. Trivedi, Tao Xu, Davide Miksa, Cortney Worrell, Chanda Macias, Ying Yang, Yanan Hu